ABSTRACT
Comprehensive analysis of triacylglycerol (TAG) regioisomers is extremely challenging, with many variables that can influence the results. Previously, we reported a novel algorithmic method for resolving regioisomers of complex mixtures of TAGs. In the current study, the TAG Analyzer software and its mass spectrometric fragmentation model were further developed and validated for a much wider range of TAGs. To demonstrate the method, we performed for the first time a comprehensive analysis of TAG regioisomers of bovine milk fat, a very important and one of the most complex TAG mixtures in nature containing FAs ranging from short to long carbon chains. This analysis method forms a solid basis for further investigation of TAG regioisomer profiles in various natural fats and oils, potentially aiding in the development of new and healthier foods and nutraceuticals with targeted lipid structures.
Subject(s)
Milk , Tandem Mass Spectrometry , Animals , Triglycerides/chemistry , Milk/chemistry , Fats/analysis , SoftwareABSTRACT
Regioisomeric analysis of triacylglycerols (TAGs) in natural oils and fats is a highly challenging task in analytical chemistry. Here we present a software (TAG Analyzer) for automatic calculation of regioisomeric composition of TAGs based on the mass spectral data from recently reported ultra-high performance liquid chromatography electrospray ionization tandem mass spectrometry (UHPLC-ESI-MS/MS) method for analyzing TAG regioisomers. The software enables fast and accurate processing of complex product ion spectra containing structurally informative diacylglycerol [M+NH4-RCO2H-NH3]+ and fatty acid ketene [RCO]+ fragment ions. Compared to manual processing, the developed software offers higher throughput with faster calculation as well as more accurate interpretation of chromatographically overlapping isobaric TAGs. The software determines results by constructing a synthetic spectrum to match the measured fragment ion spectrum, and by reporting the optimal concentrations of TAGs used to create the synthetic spectrum. This type of calculation is often extremely challenging for manual interpretation of the fragment ion spectra of isobaric TAGs with shared fragments, hence the need for automated data processing. The developed software was validated by analyzing a wide range of mixtures of regiopure TAG reference compounds of known composition and a commercial olive oil sample. Additionally, the method was also applied for regiospecific analysis of TAGs in human milk as an example of natural fats and oils with a highly complex TAG profile. The results indicate that the software is capable of resolving regioisomeric composition of natural TAGs even of the most complex composition. This novel calculation software combined with our existing UHPLC-ESI-MS/MS method form a highly efficient tool for regioisomeric analysis of TAGs in natural fats and oils.
Subject(s)
Plant Oils , Tandem Mass Spectrometry , Chromatography, High Pressure Liquid/methods , Fats , Humans , Plant Oils/chemistry , Software , Spectrometry, Mass, Electrospray Ionization/methods , Tandem Mass Spectrometry/methods , Triglycerides/analysisABSTRACT
A highly sensitive mass spectrometric (MS) method was developed and validated to analyze ratios of regioisomeric triacylglycerols (TAGs) in fats and oils. UPLC resolution of lithiated TAGs followed by daughter scan MS/MS of positive ions revealed several indicative ions for quantitative analysis. Reference TAGs containing C14-C20 fatty acids (FAs) showed good linear response. Analysis of Finnish and Chinese pooled human milk samples revealed hundreds of regioisomeric TAGs. At least 64mol% of the TAGs were quantified with relative standard deviation <17%. When present in the same TAG molecule together with C18 FAs, palmitic acid was typically in the sn-2 position. When together with FAs 10:0, 12:0, 14:0, 20:1 and 20:2, the sn-2 preference of 16:0 was less clear. Oleic acid occupied typically the sn-1/sn-3 positions but when together with FAs 20:1, 20:2, 18:2, 14:1, 12:0 or 10:0 the positioning of 18:1 did not follow these rules.
Subject(s)
Tandem Mass Spectrometry , Algorithms , Humans , Mass Spectrometry , Milk, Human , Plant Oils , Spectrometry, Mass, Electrospray Ionization , TriglyceridesABSTRACT
FNDC4 is a secreted factor sharing high homology with the exercise-associated myokine irisin (FNDC5). Here we report that Fndc4 is robustly upregulated in several mouse models of inflammation as well as in human inflammatory conditions. Specifically, FNDC4 levels are increased locally at inflamed sites of the intestine of inflammatory bowel disease patients. Interestingly, administration of recombinant FNDC4 in the mouse model of induced colitis markedly reduces disease severity compared with mice injected with a control protein. Conversely, mice lacking Fndc4 develop more severe colitis. Analysis of binding of FNDC4 to different immune cell types reveals strong and specific binding to macrophages and monocytes. FNDC4 treatment of bone marrow-derived macrophages in vitro results in reduced phagocytosis, increased cell survival and reduced proinflammatory chemokine expression. Hence, treatment with FNDC4 results in a state of dampened macrophage activity, while enhancing their survival. Thus, we have characterized FNDC4 as a factor with direct therapeutic potential in inflammatory bowel disease and possibly other inflammatory diseases.
Subject(s)
Anti-Inflammatory Agents/metabolism , Colitis/metabolism , Macrophages/metabolism , Membrane Proteins/metabolism , Proteins/metabolism , Amino Acid Sequence , Animals , Cells, Cultured , Colitis/genetics , Colitis/pathology , Dextran Sulfate , Disease Progression , Gene Expression Regulation , Humans , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Male , Membrane Proteins/chemistry , Membrane Proteins/genetics , Mice, Inbred C57BL , Mice, Knockout , Molecular Sequence Data , Phagocytosis/drug effects , Proteins/chemistry , Proteins/genetics , STAT3 Transcription Factor/metabolism , Signal Transduction/drug effects , Transforming Growth Factor beta/pharmacology , Up-Regulation/drug effectsABSTRACT
Exercise induces physiological cardiac growth and protects the heart against pathological remodeling. Recent work suggests exercise also enhances the heart's capacity for repair, which could be important for regenerative therapies. While microRNAs are important in certain cardiac pathologies, less is known about their functional roles in exercise-induced cardiac phenotypes. We profiled cardiac microRNA expression in two distinct models of exercise and found microRNA-222 (miR-222) was upregulated in both. Downstream miR-222 targets modulating cardiomyocyte phenotypes were identified, including HIPK1 and HMBOX1. Inhibition of miR-222 in vivo completely blocked cardiac and cardiomyocyte growth in response to exercise while reducing markers of cardiomyocyte proliferation. Importantly, mice with inducible cardiomyocyte miR-222 expression were resistant to adverse cardiac remodeling and dysfunction after ischemic injury. These studies implicate miR-222 as necessary for exercise-induced cardiomyocyte growth and proliferation in the adult mammalian heart and show that it is sufficient to protect the heart against adverse remodeling.
Subject(s)
Atrial Remodeling/physiology , Heart/growth & development , MicroRNAs/metabolism , Models, Cardiovascular , Myocytes, Cardiac/metabolism , Physical Conditioning, Animal/physiology , Reperfusion Injury/therapy , Adult , Animals , Cell Enlargement , Cell Proliferation/physiology , Echocardiography , Humans , Immunohistochemistry , Mice , Microscopy, Confocal , Myocytes, Cardiac/physiology , RatsSubject(s)
Energy Metabolism/physiology , Exercise/physiology , Health Status , Motor Activity/physiology , HumansABSTRACT
The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator-1α (PGC-1α) regulates metabolic genes in skeletal muscle and contributes to the response of muscle to exercise. Muscle PGC-1α transgenic expression and exercise both increase the expression of thermogenic genes within white adipose. How the PGC-1α-mediated response to exercise in muscle conveys signals to other tissues remains incompletely defined. We employed a metabolomic approach to examine metabolites secreted from myocytes with forced expression of PGC-1α, and identified ß-aminoisobutyric acid (BAIBA) as a small molecule myokine. BAIBA increases the expression of brown adipocyte-specific genes in white adipocytes and ß-oxidation in hepatocytes both in vitro and in vivo through a PPARα-mediated mechanism, induces a brown adipose-like phenotype in human pluripotent stem cells, and improves glucose homeostasis in mice. In humans, plasma BAIBA concentrations are increased with exercise and inversely associated with metabolic risk factors. BAIBA may thus contribute to exercise-induced protection from metabolic diseases.
Subject(s)
Adipose Tissue, Brown/metabolism , Adipose Tissue, White/metabolism , Aminoisobutyric Acids/pharmacology , Cardiovascular Diseases/metabolism , Liver/metabolism , Metabolic Diseases/metabolism , Adipocytes, Brown/drug effects , Adipocytes, Brown/metabolism , Adipocytes, Brown/pathology , Adipocytes, White/drug effects , Adipocytes, White/metabolism , Adipocytes, White/pathology , Adipose Tissue, Brown/cytology , Adipose Tissue, Brown/drug effects , Adipose Tissue, White/cytology , Adipose Tissue, White/drug effects , Aminoisobutyric Acids/blood , Animals , Cardiovascular Diseases/pathology , Cell Differentiation/drug effects , Exercise , Gene Expression Regulation/drug effects , Glucose Tolerance Test , Humans , Induced Pluripotent Stem Cells/drug effects , Induced Pluripotent Stem Cells/metabolism , Liver/drug effects , Metabolic Diseases/pathology , Mice , Organ Specificity/drug effects , Organ Specificity/genetics , Oxidation-Reduction/drug effects , PPAR alpha/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Phenotype , Physical Conditioning, Animal , Risk Factors , Transcription Factors/metabolism , Transcription, Genetic/drug effects , Weight Gain/drug effectsSubject(s)
Fibronectins/metabolism , Animals , Biomedical Research/trends , Body Mass Index , Dimerization , Fatty Liver/blood , Fibronectins/blood , Fibronectins/chemistry , Fibronectins/isolation & purification , Humans , Mice , Muscle, Skeletal/metabolism , Non-alcoholic Fatty Liver Disease , Obesity/metabolismABSTRACT
Exercise is known to prevent and treat metabolic diseases such as diabetes. However, the underlying mechanisms are not fully understood, and there is currently much focus on detailing such pathways. Traditionally, much emphasis has been placed on skeletal muscle; however, recently, nonmuscle organs such as adipose tissue have been highlighted in mediating protective actions after training. Moreover, novel paracrine- and endocrine-signaling molecules have been shown to trigger important responses in nonmuscle organs after exercise. This is exciting because, when administered exogenously, such signals have obvious therapeutic potential. In this review, the authors have described some general and historical aspects of training and disease protection. The authors have also highlighted some of the current knowledge on how exercise impacts nonmuscle organs.
Subject(s)
Exercise , Muscle, Skeletal/metabolism , Adipose Tissue/metabolism , Brain/metabolism , Brain/physiology , Humans , Liver/metabolism , Liver/physiology , Muscle, Skeletal/physiology , Myocardium/metabolismSubject(s)
Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/epidemiology , Fibronectins/blood , Female , Humans , MaleABSTRACT
PGC1α is a key transcriptional coregulator of oxidative metabolism and thermogenesis. Through a high-throughput chemical screen, we found that molecules antagonizing the TRPVs (transient receptor potential vanilloid), a family of ion channels, induced PGC1α expression in adipocytes. In particular, TRPV4 negatively regulated the expression of PGC1α, UCP1, and cellular respiration. Additionally, it potently controlled the expression of multiple proinflammatory genes involved in the development of insulin resistance. Mice with a null mutation for TRPV4 or wild-type mice treated with a TRPV4 antagonist showed elevated thermogenesis in adipose tissues and were protected from diet-induced obesity, adipose inflammation, and insulin resistance. This role of TRPV4 as a cell-autonomous mediator for both the thermogenic and proinflammatory programs in adipocytes could offer a target for treating obesity and related metabolic diseases.
Subject(s)
Energy Metabolism , TRPV Cation Channels/metabolism , Thermogenesis , Adipocytes/metabolism , Adipose Tissue, Brown/metabolism , Adipose Tissue, White/metabolism , Animals , Female , Gene Knockdown Techniques , Ion Channels/metabolism , Male , Mice , Mice, Inbred C57BL , Mitochondrial Proteins/metabolism , Obesity/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , TRPV Cation Channels/antagonists & inhibitors , TRPV Cation Channels/genetics , Trans-Activators/metabolism , Transcription Factors , Uncoupling Protein 1ABSTRACT
BACKGROUND: Heart failure is a growing cause of morbidity and mortality. Cardiac phosphatidylinositol 3-kinase signaling promotes cardiomyocyte survival and function, but it is paradoxically activated in heart failure, suggesting that chronic activation of this pathway may become maladaptive. Here, we investigated the downstream phosphatidylinositol 3-kinase effector, serum- and glucocorticoid-regulated kinase-1 (SGK1), in heart failure and its complications. METHODS AND RESULTS: We found that cardiac SGK1 is activated in human and murine heart failure. We investigated the role of SGK1 in the heart by using cardiac-specific expression of constitutively active or dominant-negative SGK1. Cardiac-specific activation of SGK1 in mice increased mortality, cardiac dysfunction, and ventricular arrhythmias. The proarrhythmic effects of SGK1 were linked to biochemical and functional changes in the cardiac sodium channel and could be reversed by treatment with ranolazine, a blocker of the late sodium current. Conversely, cardiac-specific inhibition of SGK1 protected mice after hemodynamic stress from fibrosis, heart failure, and sodium channel alterations. CONCLUSIONS: SGK1 appears both necessary and sufficient for key features of adverse ventricular remodeling and may provide a novel therapeutic target in cardiac disease.
Subject(s)
Cardiomyopathy, Dilated/enzymology , Heart Failure/enzymology , Immediate-Early Proteins/physiology , Protein Serine-Threonine Kinases/physiology , Ventricular Remodeling/physiology , Acetanilides/therapeutic use , Animals , Cardiomegaly, Exercise-Induced , Consensus Sequence , Disease Models, Animal , Electrocardiography , Enzyme Induction , Humans , Hypertension/complications , Immediate-Early Proteins/chemistry , Immediate-Early Proteins/deficiency , Immediate-Early Proteins/genetics , Immediate-Early Proteins/metabolism , Ion Channel Gating/drug effects , Mice , Mice, Inbred C57BL , Mice, Transgenic , NAV1.5 Voltage-Gated Sodium Channel/chemistry , NAV1.5 Voltage-Gated Sodium Channel/drug effects , NAV1.5 Voltage-Gated Sodium Channel/physiology , Phosphatidylinositol 3-Kinases/physiology , Phosphorylation , Piperazines/therapeutic use , Protein Interaction Mapping , Protein Processing, Post-Translational , Protein Serine-Threonine Kinases/chemistry , Protein Serine-Threonine Kinases/deficiency , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Ranolazine , Sodium Channel Blockers/pharmacology , Sodium Channel Blockers/therapeutic use , Tachycardia, Ventricular/enzymology , Tachycardia, Ventricular/etiologyABSTRACT
Brown fat generates heat via the mitochondrial uncoupling protein UCP1, defending against hypothermia and obesity. Recent data suggest that there are two distinct types of brown fat: classical brown fat derived from a myf-5 cellular lineage and UCP1-positive cells that emerge in white fat from a non-myf-5 lineage. Here, we report the isolation of "beige" cells from murine white fat depots. Beige cells resemble white fat cells in having extremely low basal expression of UCP1, but, like classical brown fat, they respond to cyclic AMP stimulation with high UCP1 expression and respiration rates. Beige cells have a gene expression pattern distinct from either white or brown fat and are preferentially sensitive to the polypeptide hormone irisin. Finally, we provide evidence that previously identified brown fat deposits in adult humans are composed of beige adipocytes. These data provide a foundation for studying this mammalian cell type with therapeutic potential. PAPERCLIP:
Subject(s)
Adipocytes/classification , Adipocytes/metabolism , Adipocytes, White/metabolism , Adipose Tissue, Brown/metabolism , Animals , Cell Separation , Gene Expression Profiling , Humans , Ion Channels/metabolism , Mice , Mitochondrial Proteins/metabolism , Uncoupling Protein 1ABSTRACT
Exercise benefits a variety of organ systems in mammals, and some of the best-recognized effects of exercise on muscle are mediated by the transcriptional co-activator PPAR-γ co-activator-1 α (PGC1-α). Here we show in mouse that PGC1-α expression in muscle stimulates an increase in expression of FNDC5, a membrane protein that is cleaved and secreted as a newly identified hormone, irisin. Irisin acts on white adipose cells in culture and in vivo to stimulate UCP1 expression and a broad program of brown-fat-like development. Irisin is induced with exercise in mice and humans, and mildly increased irisin levels in the blood cause an increase in energy expenditure in mice with no changes in movement or food intake. This results in improvements in obesity and glucose homeostasis. Irisin could be therapeutic for human metabolic disease and other disorders that are improved with exercise.
Subject(s)
Adipose Tissue, Brown/cytology , Adipose Tissue, White/cytology , Thermogenesis , Trans-Activators/metabolism , Adipocytes/cytology , Adipocytes/drug effects , Adipocytes/metabolism , Adipose Tissue, Brown/drug effects , Adipose Tissue, Brown/metabolism , Adipose Tissue, White/drug effects , Adipose Tissue, White/metabolism , Animals , Cell Respiration/drug effects , Cells, Cultured , Culture Media, Conditioned/pharmacology , Energy Metabolism/drug effects , Energy Metabolism/genetics , Energy Metabolism/physiology , Exercise/physiology , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Hormones/metabolism , Humans , Insulin Resistance/physiology , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Ion Channels/metabolism , Mice , Mice, Inbred BALB C , Mice, Transgenic , Mitochondrial Proteins/metabolism , Models, Animal , Muscle Cells/metabolism , Obesity/blood , Obesity/chemically induced , Obesity/prevention & control , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Physical Conditioning, Animal/physiology , Plasma/chemistry , Subcutaneous Fat/cytology , Subcutaneous Fat/drug effects , Subcutaneous Fat/metabolism , Thermogenesis/drug effects , Thermogenesis/genetics , Trans-Activators/deficiency , Trans-Activators/genetics , Transcription Factors , Uncoupling Protein 1ABSTRACT
Impaired cardiac function is associated with myocardial triglyceride accumulation, but it is not clear how the lipids accumulate or whether this accumulation is detrimental. Here we show that hypoxia/ischemia-induced accumulation of lipids in HL-1 cardiomyocytes and mouse hearts is dependent on expression of the VLDL receptor (VLDLR). Hypoxia-induced VLDLR expression in HL-1 cells was dependent on HIF-1α through its interaction with a hypoxia-responsive element in the Vldlr promoter, and VLDLR promoted the endocytosis of lipoproteins. Furthermore, VLDLR expression was higher in ischemic compared with nonischemic left ventricles from human hearts and was correlated with the total lipid droplet area in the cardiomyocytes. Importantly, Vldlr-/- mice showed improved survival and decreased infarct area following an induced myocardial infarction. ER stress, which leads to apoptosis, is known to be involved in ischemic heart disease. We found that ischemia-induced ER stress and apoptosis in mouse hearts were reduced in Vldlr-/- mice and in mice treated with antibodies specific for VLDLR. These findings suggest that VLDLR-induced lipid accumulation in the ischemic heart worsens survival by increasing ER stress and apoptosis.
Subject(s)
Myocardial Infarction/mortality , Myocardial Infarction/physiopathology , Receptors, LDL/metabolism , Triglycerides/toxicity , Animals , Apoptosis/physiology , Cell Line , Endoplasmic Reticulum/metabolism , Humans , Lipid Metabolism , Lipids/chemistry , Mice , Mice, Inbred C57BL , Mice, Knockout , Myocardial Infarction/pathology , Myocardial Ischemia/mortality , Myocardial Ischemia/pathology , Myocardial Ischemia/physiopathology , Myocardium/cytology , Myocardium/metabolism , Myocardium/pathology , Receptors, LDL/genetics , Stress, Physiological , Survival RateABSTRACT
Neutral lipids are stored in so-called lipid droplets, which are formed as small primordial droplets at microsomal membranes and increase in size by a fusion process. The fusion is catalyzed by the SNARE proteins SNAP23, syntaxin-5 and VAMP4. SNAP23 is involved in the insulin dependent translocation of GLUT4 to the plasma membrane, and has an important role in the development of insulin resistance. Thus fatty acids relocalize SNAP23 from the plasma membrane (and the translocation of GLUT 4) to the interior of the cell giving rise to insulin resistance. Moreover this relocalization is seen in skeletal muscles biopsies from patients with type 2 diabetes compared to matched control. Thus a missorting of SNAP23 is essential for the development of insulin resistance.
Subject(s)
Diabetes Mellitus, Type 2/metabolism , Insulin Resistance , Lipid Metabolism , Lipids , SNARE Proteins/metabolism , Animals , Cell Membrane/metabolism , Cell Membrane/pathology , Diabetes Mellitus, Type 2/pathology , Glucose Transporter Type 4/metabolism , Humans , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Protein Transport , Subcellular Fractions/metabolismABSTRACT
Exercise has been shown to be effective for treating obesity and type 2 diabetes. However, the molecular mechanisms for adaptation to exercise training are not fully understood. Endoplasmic reticulum (ER) stress has been linked to metabolic dysfunction. Here we show that the unfolded protein response (UPR), an adaptive response pathway that maintains ER homeostasis upon luminal stress, is activated in skeletal muscle during exercise and adapts skeletal muscle to exercise training. The transcriptional coactivator PGC-1α, which regulates several exercise-associated aspects of skeletal muscle function, mediates the UPR in myotubes and skeletal muscle through coactivation of ATF6α. Efficient recovery from acute exercise is compromised in ATF6α(-/-) mice. Blocking ER-stress-related cell death via deletion of CHOP partially rescues the exercise intolerance phenotype in muscle-specific PGC-1α KO mice. These findings suggest that modulation of the UPR through PGC1α represents an alternative avenue to improve skeletal muscle function and achieve metabolic benefits.